[Federal Register: December 30, 2003 (Volume 68, Number 249)]
[Notices]
[Page 75246-75256]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30de03-74]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
HIV Prevention Projects for the Pacific Islands
Announcement Type: New.
Funding Opportunity Number: 04069.
Catalog of Federal Domestic Assistance Number: 93.943.
Key Dates:
Application Deadline: February 2, 2004.
I. Funding Opportunity Description
Authority: This program is authorized under sections 301(a) and
317(k)(2) of the Public Health Service Act, 42 U.S.C., 241 and
247b(k)(2).
Purpose: The purpose of the program is to support HIV prevention
projects in the U.S. Affiliated Pacific Island Jurisdictions. HIV
prevention programs in these jurisdictions face unique challenges and
circumstances. These jurisdictions often lack sufficient resources,
program infrastructure, and technical support to fully implement a
comprehensive HIV prevention program and to ensure that critical
prevention program components are implemented and sustained. These
island nations deal with many challenging dynamics that include
reaching and supporting prevention activities in locations separated by
vast expanses of ocean, highly mobile populations, a lack of primary
health care providers and facilities, variable economic and social
conditions, and the challenge of adequately managing the migration and
movement of regional and international visitors and workers. This
program addresses the Healthy People 2010 focus area of HIV infection.
The majority of HIV transmission is by persons unaware of their
infection; one quarter of the people in the United States who are
infected with HIV do not yet know they are infected. Knowledge of their
HIV status would allow these people to receive the benefits of improved
treatment and care, as well as ongoing prevention services that can
help them avoid infecting others.
CDC is refocusing some HIV prevention activities to reduce the
number of new HIV infections in the United States (``Advancing HIV
Prevention: New Strategies for a Changing Epidemic--United States,''
MMWR 2003; 52(15): 329-332). This new initiative will put more emphasis
on counseling, testing, and referral for the estimated 180,000 to
280,000 persons who are unaware of their HIV infection; partner
notification, including partner counseling and referral services; and
prevention services for persons living with HIV to prevent further
transmission once they are diagnosed with HIV. In addition, since
perinatal HIV transmission can be prevented, CDC is strengthening
efforts to promote routine, universal HIV screening as a part of
prenatal care. All of this will be accomplished through four
strategies: (1) Making HIV screening a routine part of medical care;
(2) creating new models for diagnosing HIV infection, including the use
of rapid testing; (3) improving and expanding prevention services for
people living with HIV; and (4) further decreasing perinatal HIV
transmission.
Measurable outcomes of the program will be in alignment with the
following performance goals for the National Center for HIV, STD and TB
Prevention (NCHSTP):
1. Decrease the number of persons at high risk for acquiring or
transmitting HIV infection by delivering targeted, sustained, and
evidence-based HIV prevention interventions, including prevention of
perinatal HIV transmission.
2. Increase, through voluntary counseling and testing, the
proportion of HIV-infected people who know they are infected, focusing
particularly on populations with high rates of undiagnosed HIV
infection by: Incorporating HIV rapid and other test technology where
applicable; reconfiguring counseling and testing resources to increase
the efficiency of such services; increasing the number of providers who
routinely provide HIV screening in health care settings; and increasing
the number of partners who receive partner counseling, testing, and
referral services.
[[Page 75247]]
3. Increase the proportion of HIV-infected people who are linked to
appropriate prevention, care, and treatment services.
4. Strengthen the capacity of health department/ministry of health
and community-based efforts to implement effective HIV prevention
programs and to evaluate them.
To ensure quality programs and measure progress, applicants are
required to report on a set of core program performance indicators
appropriate for their program activities. (In this and other documents,
these may also be referred to as core indicators, program indicators,
performance indicators, or simply indicators). Each jurisdiction will
set annual target levels of performance for each indicator.
Funded jurisdictions are accountable for achieving their target
levels of performance. If a jurisdiction fails to achieve its target,
CDC will work with the grantee to determine how to improve performance.
CDC actions could include technical assistance, placing conditions or
restrictions on the award of funds or, with chronic failure to improve,
a reduction in funds.
Activities:
Awardee activities for this program are as follows: Recipients will
implement a comprehensive HIV prevention program that includes the
following components:
a. HIV prevention program planning and implementation using a
formal process that involves meaningful community input and involvement
b. HIV prevention activities:
(1) HIV prevention counseling, testing, and referral services (CTR)
(2) Partner notification, including partner counseling and referral
services (hereafter known as PCRS) with strong linkages to prevention
and care services
(3) Prevention for HIV-infected persons
(4) Health education and risk reduction (HE/RR) activities
Information on HIV prevention methods (or strategies) can include
abstinence, monogamy, i.e., being faithful to a single sexual partner,
or using condoms consistently and correctly. These approaches can avoid
risk (abstinence) or effectively reduce risk for HIV (monogamy,
consistent and correct condom use).
(5) Public information programs
(6) Perinatal transmission prevention
c. Evaluation of major program activities, interventions, and
services, including data collection on interventions and clients served
d. Collaboration and coordination with other related programs
e. Laboratory support
f. Core HIV/AIDS epidemiologic and behavioral surveillance
g. Quality assurance
h. Capacity-building activities are a recommended component of a
comprehensive HIV prevention program and should be implemented
depending upon program needs and availability of resources.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
CDC Activities for this program are as follows:
a. Provide consultation, technical assistance (TA), and support of
capacity-building assistance in all aspects of grantee's comprehensive
HIV prevention program, including (during the first year of this five-
year project period) extensive support and assistance to design,
develop, and implement a new model for HIV prevention planning and
implementation that will incorporate community input and involvement
b. Work with grantees to assess training needs and provide training
to managers, supervisors, and staff of CTR, outreach, or other
prevention programs, either directly or through its network of TA
providers and STD/HIV prevention training centers
c. Disseminate current information, including best practices, in
all areas of HIV prevention; facilitate the adoption and adaptation of
effective intervention models through workshops, conferences, and
written materials; and provide TA in the development and evaluation of
new or innovative prevention models
d. Develop intervention and program evaluation guidelines and
program monitoring systems (including core program indicators)
e. Facilitate coordination of activities among other CDC-funded
programs, health departments/ministries of health, community-based
organizations (CBOs), national/international capacity-building
assistance (CBA) providers, international governmental and non-
governmental agencies and organizations, and care providers and
recipients of Ryan White CARE Act funds
f. Monitor progress toward achieving target levels of performance
for each core program indicator, provide feedback, and take appropriate
steps when target levels of performance are not met
II. Award Information
Type of Award: Cooperative Agreement. CDC involvement in this
program is listed in the Activities Section above.
Fiscal Year funds: 2004.
Approximate Total Funding: $1,624,005.
Approximate Number of Awards: 6.
Approximate Average Award: $270,667.
Floor of Award Range: $130,330.
Ceiling of Award Range: $541,759.
Anticipated Award Date: April 1, 2004.
Budget Period Length: 12 months.
Project Period Length: Five years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.
III. Eligibility Information
III.1. Eligible Applicants
Applications may be submitted by the six health departments/
ministries of health of the United States Affiliated Pacific Island
Jurisdictions: American Samoa, Commonwealth of the Northern Mariana
Islands, Federated States of Micronesia, Guam, Republic of the Marshall
Islands, and Republic of Palau.
III.2. Cost Sharing or Matching
Matching funds are not required for this program.
III.3. Other
CDC will accept and review applications with budgets greater than
the ceiling of the award range.
Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.
IV. Application and Submission Information
IV.1. Address to Request Application Package
To apply for this funding opportunity use application form CDC
1246. Forms and instructions are available on the CDC Web site, at the
following Internet address: http://www.cdc.gov /od/pgo/forminfo.htm.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
[[Page 75248]]
IV.2. Content and Form of Application Submission
You must submit a signed hard copy original and two copies of your
application.
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access: http://www.dnb.com /AU/index.asp?event=
countrymenu&country=au
Or: http:// www.dunand bradsteet.com.
You may call the Dun and Bradstreet Australia office at: 61 3 9828
3448.
For more information, see the CDC Web site at: http://www.cdc.gov /
od/pgo/funding/ pubcommt.htm.
If your application form does not have a DUNS number field, please
write your DUNS number at the top of the first page of your
application, and/or include your DUNS number in your application cover
letter.
You must include a project narrative with your application forms.
Your narrative must be submitted in the following format:
[sbull] Maximum number of pages: 50 pages. If your narrative
exceeds the page limit, only the first pages, which are within the page
limit, will be reviewed.
[sbull] Font size: 12 point unreduced;
[sbull] Paper size: 8.5 by 11 inches;
[sbull] Page margin size: one inch;
[sbull] Printed only on one side of page;
[sbull] Held together only by rubber bands or metal clips; not
bound in any other way.
[sbull] The Program Announcement title and number must appear in
the application.
[sbull] Sequentially number all pages in the application and
attachments, and include a Table of Contents reflecting major
categories and corresponding page numbers.
[sbull] Provide only those attachments directly relevant to this
application.
Your narrative should address activities to be conducted over the
entire project period.
The following information describes program requirements and asks
you to describe, in your application, how you will address the
requirements. This section also includes core program performance
indicators that are required for specific program activities. These
indicators will be used to help measure program performance. In your
application, you are required to report on the base-line level for each
indicator, as well as a one-year interim target and a five-year overall
target level of achievement (a technical guide, CDC Technical
Assistance Guidelines for Health Department HIV Prevention Program
Performance Indicators, is available to assist you in understanding and
responding to the core program performance indicators). In subsequent
progress reports, you will be required to report on progress in
achieving target levels of performance for each core program
performance indicator.
If your HIV prevention program cannot currently carry out aspects
of a required HIV program activity and, as a result, limits your
ability to formulate core program performance indicator baselines and
targets, please provide a detailed description of the current status of
your jurisdiction's ability to implement that particular program
activity. In addition, please also describe your jurisdiction's needs
in terms of program capacity development or technical assistance to
implement this required HIV program activity.
a. HIV Prevention Program Planning and Implementation Using Community
Input and Involvement
(1) As part of activities covered under this announcement, grantees
will work with CDC to create and implement a suitable model that has
been specifically developed considering the existing HIV prevention
capacity and resources in the Pacific. Most of the activities related
to the development of this new model must occur during the first year
of the five-year project period.
(2) Attend and participate in CDC sponsored and supported
consultations and activities provided to develop and construct a new
model for community involvement in HIV prevention program planning and
implementation. These events will take place in the Pacific and in
other locations, as well as through facilitated teleconferences and
meetings. Ensure that adequate funds are provided to support the
development of this new HIV prevention program planning and
implementation model and that your program is sufficiently represented
during all phases of the development process
(3) Once a model for community input and involvement has been
developed and formalized, all funded grantees must ensure that this
process is implemented and supported. Reporting and evaluation
requirements regarding the implementation of this required component
would be defined and clarified during the five-year project period.
In your application:
Describe your jurisdiction's current process for ensuring that
community involvement and input is part of HIV prevention program
planning and implementation. Describe barriers, challenges and
limitations in the current process or model. Describe ideas or
suggestions for a new model that might achieve or increase community
involvement in HIV prevention program planning and implementation.
b. HIV Prevention Activities
There are two overall HIV prevention core program performance
indicators. Specify a base-line level for the following two core
program performance indicators:
[sbull] Indicator A.1: Number of newly diagnosed HIV infections;
[sbull] Indicator A.2: Proportion of HIV/AIDS cases 13-24 years of
age diagnosed each year among all HIV/AIDS cases.
(1) HIV Counseling, Testing, and Referral (CTR) Services
All jurisdictions must provide counseling, testing, and referral
services with a focus on diagnosing as many new cases of HIV as
possible and implementing HIV CTR strategies that increase
opportunities for HIV testing in populations at high risk for HIV
infection.
(a) Provide HIV CTR services. These services must be consistent
with CDC's most current HIV CTR guidelines (``CDC Revised Guidelines
for HIV Counseling, Testing, and Referral,'' MMWR 2001, 50 [RR-19]; 1-
58) and should be implemented in order to diagnose as many new HIV
infections as possible.
(b) Provide opportunities for persons to receive anonymous HIV CTR
services, unless prohibited by law or regulation.
(c) Ensure that appropriate HIV CTR services are provided in
settings most likely to reach persons who are likely to be infected,
but who are unaware of their status. Settings should include community
outreach and other non-traditional sites. These services should include
use of rapid and other test technologies (i.e., oral fluid-based test
technology), where applicable.
(d) Provide opportunities for high-risk individuals who test HIV-
negative to receive appropriate and effective HIV prevention
interventions and risk reduction counseling. Information on HIV
prevention methods (or strategies) can include abstinence, monogamy,
i.e., being faithful to a single sexual partner, or using condoms
consistently and correctly. These approaches can avoid risk
(abstinence) or effectively reduce risk for HIV (monogamy, consistent
and correct condom use).
[[Page 75249]]
(e) Ensure that clients receive test results, particularly those
who test positive.
(f) Provide support (e.g., financial, technical assistance,
training, and coordination) to health care providers to increase the
identification of HIV-positive persons through strengthening current
CTR services or creating new services. Work with departments of
corrections to encourage and, when appropriate, support routine
voluntary HIV screening and referral in correctional facilities.
Strengthen outreach into communities to increase the number of HIV
infections diagnosed by increasing the number of high-risk persons
participating in HIV counseling, testing, and referral services.
(g) Collect and report HIV CTR data as will be specified in the new
Program Evaluation and Monitoring System (PEMS), including core program
performance indicators. Report HIV CTR activities on a quarterly basis
as specified in the Technical Reporting Section of this Announcement.
(h) Seek opportunities to integrate and enhance HIV CTR and STD
services.
(i) Collect and report data that will provide useful and accurate
information on the status and function of the HIV counseling, testing,
and referral system. Ensure that there is sufficient capacity to
collect and store electronic data and that data are secure.
In your application:
(a) Describe your plan to provide HIV CTR services, including:
[sbull] How you will establish or improve efforts to identify newly
infected persons and to test persons most at risk for HIV.
[sbull] How you will improve the provision of test results
(especially positive results).
[sbull] How you will expand the availability of HIV CTR services,
especially in areas where testing is not currently available and where
high-risk populations would seek testing.
[sbull] Your plan for providing referrals and tracking the
completion of referrals for persons with positive test results.
[sbull] How you will provide HIV prevention interventions and risk
reduction counseling for high-risk persons who have negative HIV test
results.
[sbull] How you will work with medical care entities to encourage
and support routine HIV screening in high prevalence settings.
(b) Specify a base-line level, one-year interim target, and five-
year overall target level of performance for each of the following core
program performance indicators:
[sbull] Indicator B.1: Percent of newly identified, confirmed HIV-
positive test results among all tests reported by CDC-funded HIV
counseling, testing, and referral sites.
[sbull] Indicator B.2: Percent of newly identified, confirmed HIV-
positive test results returned to clients.
(2) Partner Counseling and Referral Services (PCRS)
All recipients must:
(a) Ensure that PCRS is a high priority within the jurisdiction's
HIV prevention activities. These services must be consistent with the
most current PCRS guidelines as found in HIV Partner Counseling and
Referral Services Guidance (December 30, 1998).
(b) Provide PCRS for HIV-infected persons who have been tested
anonymously or confidentially in CDC-funded sites. Ideally, PCRS should
be offered to all persons with positive test results, regardless of
where they were tested. Make a good faith effort to notify sexual or
needle-sharing partners. PCRS efforts should be documented. Collaborate
with the STD program and other health care providers to provide PCRS.
(c) Develop a plan to implement new techniques and approaches to
increase PCRS, using such things as social networks and incentives.
(d) Collect and report PCRS data consistent with core data elements
as will be specified in PEMS, including core program indicators.
In your application:
(a) Describe your current system for providing HIV Partner
Counseling and Referral Services. Also describe your plan to provide
PCRS for individuals who travel and migrate across jurisdictions within
the Pacific, Hawaii, and the U.S. mainland, and how you will address
the provision of PCRS for clients coming to or from non-health
department/non-ministry of health settings.
(b) Specify a base-line level, one-year interim target, and five-
year overall target level of performance for each of the following core
program performance indicators:
[sbull] Indicator C.1: Percent of contacts with unknown or negative
serostatus who receive an HIV test after PCRS notification
[sbull] Indicator C.2: Percent of contacts with a newly identified,
confirmed HIV-positive test among contacts that are tested
[sbull] Indicator C.3: Percent of contacts with a known, confirmed
HIV-positive test among all contacts
(3) Prevention for HIV-Infected Persons
All recipients must:
(a) Provide prevention services to persons infected with HIV/AIDS.
These services could include individual or group HIV risk reduction and
prevention counseling.
(b) Provide HIV risk reduction counseling to HIV-positive persons
when they are given their test results, and continue to seek
opportunities to provide HIV risk reduction counseling and
interventions to HIV-positive individuals at intervals following the
initial disclosure of test results.
Information on HIV prevention methods (or strategies) can include
abstinence, monogamy, i.e., being faithful to a single sexual partner,
or using condoms consistently and correctly. These approaches can avoid
risk (abstinence) or effectively reduce risk for HIV (monogamy,
consistent and correct condom use).
(c) Work with primary care providers in the community that serve
persons with or at risk for HIV to integrate HIV prevention services
into care and treatment services.
(d) Collect and report data on prevention for HIV-positives,
including core indicators, as will be specified in PEMS.
In your application:
(a) Describe your plan to provide prevention services for people
living with HIV/AIDS. Describe how you will provide ongoing HIV risk
reduction counseling and other interventions to HIV-positive persons.
(b) Describe how you will encourage primary care providers to
integrate prevention and care services.
(4) Health Education and Risk Reduction Services (HE/RR)
This includes individual, group, community, and structural level
interventions as well as outreach for high-risk seronegative and
seropositive individuals.
All recipients must:
(a) Provide HE/RR services or fund providers that:
[sbull] Target those most at risk for transmitting or acquiring HIV
infection.
[sbull] Implement interventions that are based on logic model,
scientific theory, or have evidence of demonstrated or probable outcome
effectiveness (see CDC's Compendium of HIV Prevention Interventions
with Evidence of Effectiveness, 1999).
[sbull] Are carried out and directed by written procedures or
protocols.
[sbull] Are acceptable to and understood by the target population,
i.e., they are culturally appropriate.
(b) Develop a plan for how you will work to establish or expand
community capacity to provide, or assist the health
[[Page 75250]]
department or ministry of health to implement, HIV prevention
interventions and activities.
(c) Collect and report data on HE/RR activities including core
indicators as will be specified in PEMS.
In your application:
(a) Identify and list priority populations and the HE/RR activities
and interventions that will be funded and carried out for each
prioritized population in the first year of the five-year project
period. This prioritization process should consider all epidemiologic
data and other evidence that is known about HIV/AIDS in the
jurisdiction, and ensure that HIV positive individuals are the priority
for prevention efforts.
(b) Describe your plan to establish and develop community capacity
to assist with or provide HIV prevention services and interventions.
Identify any existing providers, by prioritized populations and
interventions that are currently funded or will be funded in this
project period.
(c) Specify base line, one-year interim target, and five-year
overall target levels of performance for the following core program
indicator:
[sbull] Indicator H.3: the mean number of outreach contacts
required to get one person to access any of the following services:
counseling and testing, STD screening and testing, individual level
interventions (ILI), or group level interventions (GLI)
(5) Public Information Programs
All recipients must:
(a) Develop public information programs and campaigns based on
local needs with the involvement and input of the community.
(b) Collect and report data on public information activities as
will be specified in PEMS.
In your application:
Describe your plan to develop and carry out HIV prevention public
information programs. Describe the basic approach and messages that
will be developed, including how and where the information will be
disseminated. Describe how you will collect and analyze information to
determine the scope and reach of public information programs, and how
you intend to evaluate program components in order to guide and adjust
future activities. Complete this section only if you are requesting
program funds to support public information programs.
(6) Perinatal Transmission Prevention
All recipients must:
(a) Work with all health-care providers to promote routine,
universal HIV screening to all of their pregnant patients. The
Department of Health and Human Services recommends that all pregnant
women in the United States be tested for HIV infection (see ``Revised
Recommendations for HIV Screening of Pregnant Women,'' MMWR 2001; 50
(RR19); 59-86 and ``Advancing HIV Prevention: New Strategies for a
Changing Epidemic--United States,'' MMWR 2003; 52 (15); 329-332).
(b) Work with organizations, institutions and health care workers
that provide prenatal and postnatal care for HIV-infected women to
ensure that these women are receiving the appropriate HIV prevention
counseling, testing, and therapies needed to reduce the risk of
perinatal transmission.
In your application:
(a) Describe the current system of perinatal care that exists
within the jurisdiction, including:
[sbull] Who provides the care.
[sbull] How this care is monitored and managed.
[sbull] How you will work with health care providers to promote
routine, universal HIV screening to their pregnant patients.
[sbull] How you will work with organizations and institutions that
provide prenatal and postnatal care for HIV-infected women to ensure
that they are receiving the appropriate HIV prevention counseling,
testing, and therapies needed to reduce the risk of transmission.
(b) Specify base-line level, one-year interim target, and five-year
overall target levels of performance for the following core program
indicator:
[sbull] Indicator D.1: Proportion of women who receive an HIV test
during pregnancy.
c. Evaluation
All recipients must:
(1) Conduct program evaluation. Follow the requirements for the new
Program Evaluation and Monitoring System (PEMS) that will be specified
in a forthcoming HIV program evaluation guidance. PEMS will be
developed and implemented during the course of this five-year project
period.
(2) Collect and report data for the core program performance
indicators and for HIV prevention activities as specified in this
Program Announcement and in a forthcoming HIV prevention program
evaluation guidance. Respond only to the indicators that are
specifically noted and required in this Program Announcement. For each
core indicator, provide the information as specified on the indicator
reporting form (see CDC Technical Assistance Guidelines for Health
Department HIV Prevention Program Performance Indicators and as posted
on a CDC Web site).
(3) Describe current HIV program evaluation activities that address
the following topics:
[sbull] How your jurisdiction will meet the minimum data
requirements for counseling, testing, and referral.
[sbull] Your current system of data collection and reporting of HIV
prevention activities, including data system specifications and data
management information systems.
[sbull] Procedures for ensuring that data quality and data security
are consistent with CDC guidelines.
For 2005 and beyond, develop and implement a comprehensive
evaluation plan that includes all of the above elements and addresses
issues to be specified in a forthcoming HIV prevention program
evaluation guidance. This future evaluation plan should include the
following:
[sbull] A system for collection of process monitoring data,
including client-level information.
[sbull] Data entry into CDC's browser-based system or a local
system that is compatible with CDC's requirements, as outlined in the
most current evaluation guidance.
[sbull] Adherence to HIV program evaluation reporting requirements
for community input and involvement in the HIV prevention program
planning and implementation model and process that will be developed
during the first year of the five-year project period.
(4) Identify the prioritized populations and prevention activities
funded under this cooperative agreement.
(5) Collect and report data consistent with the CDC requirements to
ensure client confidentiality and security.
(6) Use either the CDC data system or compatible local systems to
report data electronically as specified in the most recent evaluation
guidance.
In your application:
(1) Describe your evaluation of HIV prevention activities for the
first year of the five-year project period.
(2) Provide copies of your local data collection instruments, local
program evaluation and data management system functions and
specifications, and any jurisdiction-wide uniform data reporting forms,
if they exist.
d. Collaboration and Coordination
All recipients must:
Coordinate and collaborate with other Pacific Islands (especially
those covered under this program announcement), agencies,
organizations, and providers to strengthen HIV prevention and care
activities and minimize duplication of
[[Page 75251]]
effort in the jurisdiction. Meaningful coordination and collaboration
efforts are characterized by joint participatory planning to address
common areas of service need; development of recommendations for
program planning and implementation; development of relevant policy
and/or legislative initiatives; identification of specific steps for
furthering collaborative efforts within defined time-frames; and
outcomes that reflect HIV prevention program goals. At a minimum,
recipients are expected to coordinate and collaborate with the
following:
(1) STD Prevention Programs
(a) Support efforts to identify persons with STDs that may
facilitate the transmission of HIV infection.
[sbull] STD diagnosis is funded primarily through the STD
prevention cooperative agreement. However, HIV prevention funds may be
used to augment STD detection services if there is a documented
opportunity to enhance HIV prevention efforts, e.g., encourage and
offer screening for syphilis in areas experiencing syphilis outbreaks.
[sbull] Funds may be used to underwrite the cost of STD treatment,
as it relates to HIV prevention, only on a case-by-case basis, and only
after approval by CDC.
[sbull] When feasible, HIV counseling and testing sites, including
outreach settings, should offer STD diagnostic services and referrals
for STD treatment.
(b) Whenever appropriate, incorporate STD prevention messages into
HIV prevention messages.
(c) Collaborate with STD programs to provide PCRS.
(2) HIV/AIDS Care Programs
To ensure early treatment and coordinate health education and risk
reduction services for HIV-positive individuals, jurisdictions are
encouraged to collaborate with providers and planners of care services
for persons living with HIV/AIDS, particularly those funded by the
Health Resources and Services Administration (HRSA) through its Ryan
White CARE Act programs. These programs include Title I Planning
Councils; Title II consortia, Special Projects of National
Significance, HIV/AIDS CBOs, and community groups; Title III Early
Intervention Services Programs; and, Title IV Programs serving
children, youth, women and their families. For a list of currently
funded CARE Act Programs and for more information on the Ryan White
CARE Act, please go to http://hab.hrsa.gov/.
(3) Other Programs
Collaboration and coordination should also occur with the
following:
[sbull] Substance abuse prevention and treatment programs and other
drug treatment or detoxification programs.
[sbull] Juvenile and adult criminal justice, correctional, and
parole systems and programs.
[sbull] Hepatitis prevention programs--Support local efforts to
integrate viral hepatitis services into existing public health programs
serving persons at risk for multiple infections (including HIV, STDs,
and hepatitis A, B, and C).
--When possible, HIV prevention services should include screening for
hepatitis viruses, e.g., hepatitis A and B in men who have sex with men
(MSM) and hepatitis B and C in injection drug users, and provide or
link those needing immunizations for hepatitis A and B to such
services. HIV funds may be used for hepatitis testing, but not
immunizations against hepatitis A or B.
--Collaborate with Hepatitis Coordinators in your jurisdiction to
integrate services where feasible.
[sbull] TB clinics and programs.
[sbull] Public mental health departments and community mental heath
centers.
[sbull] Family planning and women's health programs, including
providers of services to women in high-risk situations.
[sbull] Educational agencies: Schools, boards of education,
universities' schools of public health, and schools of nursing.
[sbull] Other community groups, businesses, and faith-based
organizations.
In your application:
Describe your plans to collaborate and coordinate HIV prevention
services and activities with the jurisdictions, programs and groups
listed above. Also, describe the intended outcomes of your
collaboration and coordination efforts, and your plan to strengthen
these activities over the five-year project period.
e. Laboratory Support
All recipients should:
Use program funds to support the cost of HIV testing for specimens
obtained via counseling and testing activities, including rapid tests
and CD4 and viral load tests. Grantees must ensure that their testing
laboratories provide tests of adequate quality, report findings
promptly, and participate in a laboratory performance evaluation
program for HIV 1 antibody testing. Grantees are encouraged to consider
using a regional lab to maximize cost effectiveness and test quality.
Jurisdictions should establish set protocols for the collection,
maintenance, testing, tracking, and shipment of specimens that need
laboratory confirmation. Grantees should develop and utilize testing
methods and procedures that ensure the most effective testing outcomes.
Grantees must ensure that adequate resources and supplies are available
to ensure the safety of the blood supply in the jurisdiction.
Jurisdictions are encouraged to consider the use of oral fluid-based
and rapid HIV test kits.
In your application:
Briefly describe all laboratory support activities funded under
this announcement. Describe your current or proposed methods for
testing and confirmation of HIV and tell us also how you would expand
testing options if laboratory capacity were enhanced and stabilized in
the Region. Include in this description a detailed algorithm of how HIV
tests are collected and processed, and how decisions are made to
determine needs for confirmation.
f. HIV/AIDS Epidemiologic and Behavioral Surveillance
All recipients must:
(1) Respond to the surveillance data needs of HIV prevention
program managers and planning bodies, including analysis,
interpretation, and presentation of surveillance data; preparation of
the epidemiologic profiles; and other reports for use in the support of
the implementation and evaluation of HIV prevention activities.
Although the Surveillance Cooperative Agreement can provide support to
jurisdictions to meet surveillance needs, funds under this announcement
may be used to help support unmet HIV/AIDS surveillance activities as
described above. Funds may also be used to address data gaps or unmet
state or local needs for supplemental surveillance, HIV incidence
surveillance, or behavioral surveillance.
(2) Collaborate with surveillance programs to collect data needed
for HIV incidence surveillance efforts.
(3) Collaborate with CDC for surveillance activities.
(4) For jurisdictions not yet reporting HIV or AIDS to CDC,
determine the steps that are necessary to ensure that accurate,
confidential and timely reporting of HIV and AIDS cases can be made to
CDC.
In your application:
Describe any surveillance activities you expect to conduct with
support provided through this program announcement. Complete this
section
[[Page 75252]]
only if you are requesting program funds to support this activity.
g. Quality Assurance
Recipients should develop, implement, and maintain quality
assurance plans in the following program areas:
(1) CTR and PCRS:
(a) Counseling--Conduct routine, periodic assessments to ensure
that the counseling being provided includes the recommended, essential
counseling elements. Quality assurance elements may include (but are
not limited to) the following components: training and continuing
education; supervisor observation with feedback to counselors; case
conferences; counselor or client satisfaction evaluations; and periodic
evaluation of space, flow, and time concerns.
(b) HIV Testing--Develop and implement a quality assurance system
for all CTR and PCRS activities and providers, with special attention
to ensuring that HIV-positive clients learn their test results. Develop
and implement a quality assurance system for implementing HIV rapid
testing.
(c) Referral--Develop and implement a mechanism for assessing the
proportion of HIV-positive persons referred for additional services who
complete their referrals. Review data and improve process as necessary.
(d) PCRS--Develop, implement, and maintain a system to assess the
PCRS program and improve its function, e.g., improving the percentage
of persons who receive PCRS, the quality of PCRS interview sessions,
and the successful notification of partners.
(2) Health Education and Risk Reduction (HE/RR) Activities:
(a) Develop and implement a mechanism to ensure HE/RR activities
are appropriate, understandable and acceptable for the specific
populations served.
(b) Develop and maintain a mechanism to ensure the consistency,
accuracy, and relevance of information provided to the public through
various information dissemination channels, including information about
referral services.
(c) Develop or use standard procedures or protocols for
interventions implemented by the health department/health ministry or
by any subcontracted providers.
(d) Actively monitor services and programs provided by individuals
or entities outside of the health department or health ministry. This
activity will help to identify training and technical assistance needs
and to ensure that interventions are implemented as planned and that
program objectives are met.
(e) Use feedback from client satisfaction surveys or other
evaluation tools to assess the services provided, including prevention
services for people living with HIV/AIDS.
(3) Policies, Procedures, and Training
(a) Develop comprehensive written quality assurance policies and
procedures to ensure that all HIV prevention activities are delivered
in an appropriate, competent, consistent, and sensitive manner.
(b) Make quality assurance policies and procedures available to all
program staff (health department/health ministry and any subcontracted
providers).
(c) Deliver training to all staff providing HIV prevention
activities, especially those staff providing CTR, PCRS, and HE/RR
(health department/health ministry and subcontracted providers).
(d) Train all managers to ensure that quality assurance policies
and procedures are followed (health department/health ministry and
subcontracted providers).
(4) Data Collection--Develop, implement, and maintain a system to
assess the quality of data collection:
In your application:
Describe your quality assurance efforts regarding HIV CTR, PCRS,
HE/RR, public information campaigns, data collection, training, program
procedures, and any other relevant programmatic areas for which you
have quality assurance plans.
h. Recommended Program Activities
This section describes capacity building, a program component that
is not required through this program announcement. However, capacity
building is recommended to improve the overall quality of your HIV
prevention program and should be implemented depending upon program
needs and availability of resources. Capacity building activities are
as follows:
(1) Conduct a capacity building needs assessment for the
jurisdiction's health department/health ministry HIV prevention service
providers and other prevention agencies/partners including community-
based organizations. This assessment should look at the capacity to
provide outreach testing, PCRS, and prevention for people living with
HIV.
(2) Develop a comprehensive capacity-building plan based on the
assessment.
(3) Provide capacity-building assistance, based on the needs
assessment, to HIV prevention service providers, and other prevention
agencies/partners. Create linkages with national and international
capacity-building assistance providers (CBAs), where necessary and
appropriate. Capacity-building assistance may include, but should not
be limited to:
(a) Strengthening organizational infrastructure, including
financial management and compliance with grant regulations.
(b) Enhancing the design, implementation, and evaluation of HIV
prevention interventions.
(c) Developing community infrastructure.
(d) Developing and implementing a new model for HIV prevention
program planning that utilizes community involvement and input.
(4) Provide capacity-building assistance to staff of health
department/health ministry HIV prevention programs and other staff.
(5) Provide capacity-building assistance to establish or develop
community-based agencies or organizations to provide outreach testing
and PCRS, including the use of rapid tests.
(6) Increase the capacity of medical providers to provide routine
HIV testing, including the use of rapid HIV tests.
(7) Provide capacity-building assistance to develop, pilot, and
sustain prevention interventions for persons living with HIV/AIDS and
other prioritized target populations.
In your application:
(1) Describe your capacity-building activities in the areas listed
above.
(2) Discuss your plans to strengthen your capacity-building
activities over the five-year project period of this program
announcement.
(3) Discuss how you will assess (initially, as well as ongoing)
capacity-building needs throughout the project period.
i. Additional Information To Be Addressed in the Application Content
(1) Other Activities
All recipients must ensure that appropriate health department/
ministry of health staff attends CDC-sponsored meetings, i.e., the
National HIV Prevention Conference, the United States Conference on
AIDS, and any mandatory training sessions addressing specific HIV
prevention program requirements under this cooperative agreement.
In your application:
(a) Budget funds provided through this cooperative agreement for
three persons to attend at least three CDC-
[[Page 75253]]
sponsored conferences or meetings each year. Also, for the first year
of this project period, budget funds for meetings/activities related to
the development of a new model for HIV prevention program planning and
implementation.
(b) Describe any other planned travel or attendance at conferences
or meetings not previously addressed.
(2) Summarize Unmet Needs
In your application:
Summarize any HIV prevention needs that will remain unmet even if
the total application is funded. Provide an estimate of funds required
to meet these needs.
(3) Management and Staffing Plan
All recipients must have the staff and infrastructure to implement
the components of a comprehensive HIV prevention program for their
jurisdiction. Recipients must maintain appropriate staffing to fulfill
their responsibility to support programs and services provided directly
by the health department/ministry of health or through community-based
organizations or efforts; provide evaluation, and quality assurance;
and support a community-driven process for HIV prevention program
planning and implementation that will guide the disbursement and
monitoring of funds.
In your application:
Describe your management and staffing plans to conduct or support
the essential components of your comprehensive HIV prevention program.
Please include an organizational chart that reflects the current
management structure and a description of the roles, responsibilities,
and relationships of all staff in the program, regardless of funding
source. Identify the positions supported through this cooperative
agreement and those funded through other sources, as well as any
unfunded staffing needs.
j. Budget Information
In accordance with Form CDC 0.1246, http://www.cdc.gov/od/pgo/forminfo.htm (http://www.cdc.gov/od/pgo/forms/01246.pdf), provide a
), provide a
line item budget and narrative justification for all requested costs
that are consistent with the purpose, objectives, and proposed program
activities. Within this budget, please provide documentation for each
cost category.
(1) Line item breakdown and justification for all personnel, i.e.,
name, position title, annual salary, percentage of time and effort, and
amount requested.
(2) Line item breakdown and justification for all contracts,
including: (a) Name of contractor, (b) period of performance, (c)
method of selection (i.e., competitive or sole source), (d) description
of activities, (e) target population and (f) itemized budget.
(3) Requests for any new Direct Assistance Federal assignees
include:
[sbull] Justification for request.
[sbull] The number of assignees requested.
[sbull] A description of the position and proposed duties.
[sbull] The ability or inability to hire locally with financial
assistance.
[sbull] An organizational chart and the name of the intended
supervisor.
[sbull] The availability of career-enhancing training, education,
and work experience opportunities for the assignee(s).
[sbull] Assignee access to computer equipment for electronic
communication with CDC.
(4) Use of Funds/Funding Priorities: Funds may not be used to
supplant other funds available for HIV prevention. Funds may not be
used to provide direct patient medical care, e.g., ongoing medical
management and provision of medications.
(5) Carryover Funds: Carryover funds are available only from the
previous 12-month budget period. Carryover funds are not available
after the end of the five-year project period.
IV.3. Submission Dates and Times
Application Deadline Date: February 2, 2004.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date. If you send your application by the United States Postal Service
or commercial delivery service, you must ensure that the carrier will
be able to guarantee delivery of the application by the closing date
and time. If CDC receives your application after closing due to: (1)
Carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carriers guarantee. If the documentation
verifies a carrier problem, CDC will consider the application as having
been received by the deadline.
This program announcement is the definitive guide on application
format, content, and deadlines. It supersedes information provided in
the application instructions. If your application does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that you did not meet the submission
requirements.
CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: 770-488-2700. Before calling, please wait two to three days after
the application deadline. This will allow time for applications to be
processed and logged.
IV.4. Intergovernmental Review of Applications
Your application is subject to Intergovernmental Review of Federal
Programs, as governed by Executive Order (EO) 12372. This order sets up
a system for state and local governmental review of proposed federal
assistance applications. You should contact your state single point of
contact (SPOC) as early as possible to alert the SPOC to prospect
applications, and to receive instructions on your state's process.
Click on the following link to get the current SPOC list: http://www.whitehouse.gov/omb/grants/spoc.html
IV.5. Funding Restrictions
Funds may not be used to supplant other funds available for HIV
prevention. Funds may not be used to provide direct patient medical
care, e.g., ongoing medical management and provision of medications.
Funds may be used to underwrite the cost of STD treatment, as it
relates to HIV prevention, only on a case-by-case basis, and only after
approval by CDC.
HIV funds may be used for hepatitis testing, but not immunizations
against hepatitis A or B.
Awards will not allow reimbursement of pre-award costs.
IV.6. Other Submission Requirements
Application Submission Address: Submit the original and two copies
of your application by mail or express delivery service to: Technical
Information management--PA 04069, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta, GA 30341.
Applications may not be submitted electronically at this time.
V. Application Review Information
V.1. Criteria: You are required to provide measures of
effectiveness that will demonstrate the accomplishment of the various
identified objectives of the cooperative agreement. Measures of
effectiveness must relate to the performance goals stated in the
[[Page 75254]]
``Purpose'' section of this announcement. Measures must be objective
and quantitative, and must measure the intended outcome. These measures
of effectiveness must be submitted with the application and will be an
element of evaluation. Compliance with core program performance
indicators will fulfill the above requirement.
Your application will be evaluated against the criteria listed
below. All criteria are weighted equally.
1. HIV Prevention Program Planning and Implementation Using Community
Input and Involvement
Does the applicant describe their jurisdiction's current process
for ensuring that community involvement and input is part of HIV
prevention program planning and implementation. Describe barriers,
challenges and limitations in the current process or model. Describe
ideas or suggestions for a new model that might achieve or increase
community involvement in HIV prevention program planning and
implementation.
2. HIV Prevention Activities
(a) Does the applicant describe their plan to provide HIV CTR,
including:
[sbull] How the applicant will establish or improve efforts to
identify newly infected persons and to test persons most at risk for
HIV.
[sbull] How the applicant will improve the provisions of test
results (especially positive results).
[sbull] How the applicant will expand the availability of HIV CTR
services, especially in areas where testing is not currently available
and where high risk populations would seek testing.
[sbull] Does the applicant have a plan for providing referrals and
tracking the completion of referrals for persons with positive test
results?
[sbull] How the applicant will work with medical care entities to
encourage and support routine HIV screening in high prevalence
settings.
(b) Does the applicant specify a base-line level, one-year interim
target, and five-year overall target level of performance for each of
the following core program indicators?
[sbull] Indicator B.1: Percent of newly identified, confirmed HIV-
positive test results among all tests reported by CDC-funded HIV
Counseling, testing, and referral sites.
[sbull] Indicator B.2: percent of newly identified, confirmed HIV
positive test results returned to clients.
3. Partner Counseling and Referral Services (PCRS)
(a) Does the applicant describe their current system for providing
HIV Partner Counseling and Referral Services? Also, do they describe
their plan to provide PCRS for individuals who travel and migrate
across jurisdictions within the Pacific, Hawaii, and the U.S. mainland,
and how will they address the provision of PCRS for clients coming to
or from non-health department/non-ministry of health settings.
(b) Does the applicant specify a base-line level, one-year interim
target, and five-year overall target level of performance for each of
the following core program indicators?
[sbull] Indicator C.1: Percent of contacts with unknown or negative
serostatus who receives an HIV test after PCRS notification.
[sbull] Indicator C.2: Percent of contacts with a newly identified,
confirmed HIV-positive test among contacts who are tested.
[sbull] Indicator C.3: Percent of contacts with a known, confirmed
HIV-positive test among all contacts.
4. Prevention for HIV-Infected Persons
(a) Does the applicant describe their plan to provide prevention
services for people living with HIV/AIDS? Does the applicant describe
how they will provide ongoing HIV risk reduction counseling and other
interventions to HIV positive persons?
(b) Does the applicant describe how they will encourage primary
care providers to integrate prevention and cares services?
5. Health Education and Risk Reduction Services (HE/RR)
(a) Does the applicant Identify and list priority populations and
the health education/risk reduction activities and interventions that
will be funded and carried out for each prioritized populations in the
first year of the five-year project period? (Use Draft Priority
Population Summary Worksheet.) This priorization process should
consider all epidemiologic data and other evidence that is known about
HIV/AIDS in the jurisdiction, and ensure that HIV positive individuals
are the priority for prevention efforts.
(b) Does the applicant describe their plan to establish and develop
community capacity to assist with or provide HIV prevention services
and interventions? Identify any existing providers, by prioritized
populations and interventions that are currently funded or will be
funded in this project period.
(c) Specify base-line, one year-year interim target, and five-year
overall target levels of performance for the following core program
indicator:
[sbull] Indicator H.3: The mean number of outreach contacts
required to get one person to access any of the following services:
counseling and testing, STD screening and testing, individual level
interventions (ILI), or group level interventions (GLI).
6. Public Information Programs
(a) Does the applicant describe their plan to develop and carry out
HIV prevention public information programs? Do they describe the basic
approach and messages that will be developed, including how and where
the information will be disseminated? Does the applicant describe how
they will collect and analyze information to determine the scope and
reach of public information programs, and how they intend to evaluate
program components in order to guide and adjust future activities?
7. Perinatal Transmission Prevention
(a) Does the applicant describe the current system of perinatal
care that exists within the jurisdiction, including:
[sbull] Who provides the care.
[sbull] How this care is monitored and managed.
[sbull] How they will work with health care providers to promote
routine, universal HIV screening to their pregnant patients.
[sbull] How they will work with organizations and institutions that
provide prenatal and postnatal care for HIV-infected women to ensure
that they are receiving the appropriate HIV prevention counseling,
testing, and therapies needed to reduce the risk of transmission.
(b) Does the applicant specify base-line level, one-year interim
target, and five-year overall target levels of performance for the
following core program indicator:
[sbull] Indicator D.1: Proportion of women who receive an HIV test
during pregnancy.
8. Evaluation
(a) Does the applicant describe their plan for evaluation of HIV
prevention activities for the first year of the five-year project
period?
(b) Does the applicant provide copies of their local data
collection instruments, local program evaluation and data management
system functions and specifications, and any jurisdiction-wide uniform
data reporting forms, if they exist.
[[Page 75255]]
9. Collaboration and Coordination
Does the applicant describe their plans to collaborate and
coordinate HIV prevention services and activities with the
jurisdictions, programs and groups listed in this announcement? Also,
how do they describe the intended outcomes of their collaboration and
coordination efforts, and their plan to strengthen these activities
over the five-year project period?
10. Laboratory Support
Does the applicant briefly describe all laboratory support
activities funded under this announcement? Does the applicant describe
their current or proposed methods for testing and confirmation of HIV,
and describe also how they would expand testing options if laboratory
capacity were enhanced and stabilized in the region? Did they include
in this description a detailed algorithm of how HIV tests are collected
and processed, and how decisions are made to determine needs for
confirmation?
11. HIV/AIDS Epidemiologic and Behavioral Surveillance
Does the applicant describe any surveillance activities they expect
to conduct with support provided through this program announcement?
[Note to applicant: Complete this only if you are requesting program
funds to support this activity.]
12. Quality Assurance
Does the applicant describe their quality assurance efforts
regarding HIV CTR, PCRS, HE/RR, public information campaigns, data
collection, training, program procedures, and any other relevant
programmatic areas for which they have quality assurance plans?
13. Capacity-Building Activities (Recommended Activity Based on
Availability of Resources)
(a) Does the applicant describe their capacity-building activities
in the areas listed?
(b) Does the applicant discuss their plans to strengthen their
capacity-building activities over the five-year project period of this
program announcement?
(c) Does the applicant discuss how they would assess (initially, as
well as ongoing) capacity-building needs throughout the project period?
14. Other Activities
(a) Does the applicant budget funds through this cooperative
agreement for three persons to attend at least three CDC-sponsored
conferences or meetings each year? Also, for the first year of this
project period, does the applicant budget funds for meetings/activities
related to the development of a new model for HIV prevention program
planning and implementation?
(b) Does the applicant describe any other planned travel or
attendance at conferences or meetings not previously addressed?
15. Unmet Needs
Does the applicant summarize any HIV prevention needs that will
remain unmet even if the total application is funded? Do they provide
an estimate of funds required to meet these needs?
16. Management and Staffing Plan
Does the applicant describe their management and staffing plan to
conduct or support the essential components of their comprehensive HIV
prevention program? Does the applicant include an organizational chart
that reflects the current management structure and a description of the
roles, responsibilities, and relationships of all staff in the program,
regardless of funding source? Does the applicant identify the positions
supported through this cooperative agreement and those funded through
other sources, as well as any unfounded staffing needs?
V.2. Review and Selection Process
As all eligible applicants will be funded, applications will
undergo a Technical Acceptability Review.
V.3. Anticipated Announcement and Award Date
Award Date: April 1, 2004.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Grant Award (NGA)
from the CDC Procurement and Grants Office. The NGA shall be the only
binding, authorizing document between the recipient and CDC. The NGA
will be signed by an authorized Grants Management Officer, and mailed
to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2. Administrative and National Policy Requirements:
45 CFR Part 74 and Part 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html
The following additional requirements apply to this project:
AR-4 HIV/AIDS Confidentiality Provisions
AR-5 HIV Program Review Panel Requirements
AR-7 Executive Order 12372 Review
AR-8 Public Health System Reporting Requirements
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-14[cent]Accounting System Requirements
AR-16 Security Clearance Requirement
AR-20 Conference Support
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
VI.3. Reporting Requirements
You must provide CDC with a hard copy original, plus two copies of
the following reports:
1. Data reports of HIV interventions (including individual and
group level); outreach; health communication/public information; HIV
counseling, testing, and referral; partner counseling and referral
service; are required 45 days after the end of each quarter or as
specified in the most recent evaluation guidance. Project areas may
request technical assistance to achieve this. Data should be submitted
directly to the Program Evaluation Research Branch.
2. This program requires progress reports on a semi-annual basis.
The first progress report (an original plus two copies) for each
calendar year is due by April 1 of the following year. You will receive
specific guidance on what to include at least three months before the
due date. Generally, your report should include the following:
a. Base-line and actual level of performance on core and optional
indicators
b. Current Budget Period Financial Progress
c. Additional Requested Information
3. The second report (an original and two copies), which is the
interim progress report, is due by September 30 of each year. It should
include:
a. Current Budget Period Financial Progress
b. Base-line and target level for core and optional indicators
c. Detailed Line-Item Budget and Justification
d. Additional Requested Information
4. Provide CDC with a Financial Status Report (original and two
copies),
[[Page 75256]]
no more than 90 days after the end of each budget period.
5. Provide CDC with your final financial and performance reports
(original and two copies), no more than 90 days after the end of the
five-year project period.
6. Submit any newly developed public information resources and
materials to the CDC National Prevention Information Network (formerly
the AIDS Information Clearinghouse) so that they can be incorporated
into the current database for access by other organizations and
agencies.
Submit hard copies of materials to: CDC National Prevention
Information Network, Attention Database Services, PO Box 6003,
Rockville, MD 20849-6003; or submit electronic copies of materials by
email to: info@cdcnpin.org; Subject: Database Services, For more
information call: 1-800-458-5231.
7. HIV Content Review Guidelines
a. Submit completed Assurance of Compliance with the Requirements
for Contents of AIDS-Related Written Materials Form (CDC form-0.1113)
with your application. This form, which lists the members of your
program review panel, can be downloaded from the CDC Web site: http://www.cdc.gov/od/pgo/forminfo.htm.
The Program Director and authorized
business/fiscal official must sign this form. In addition, you must
certify that your program review panel represents a reasonable cross-
section of the community in which the program is based.
b. You must also include with your application documentation of
approval/disapproval by your program review panel of any HIV
educational materials that you are currently using. Use the form,
Report of Approval/Disapproval for this purpose. This form is attached
to this announcement as posted on the CDC Web site. If you have
previously sent this information to CDC, it is not necessary to send it
again. If you have nothing to submit, you must complete the enclosed
form, No Report Necessary. Either the Report of Approval/Disapproval or
No Report Necessary must be included with your application, all
progress reports, and all continuation requests. In addition to using
the Report of Approval/Disapproval, you must certify that accountable
jurisdictional health officials independently review the federally-
funded HIV prevention materials for compliance with Section 2500 of the
Public Health Service Act, and approve the use of such materials in
their jurisdiction for directly and indirectly funded organizations.
c. Ensure that a Web page notice be used for those grantees whose
Web sites contain HIV/AIDS educational information subject to the CDC
content review guidelines. Contact your project officer for a copy of
this guidance.
8. Address your organization's compliance with CDC policies for
securing approval for CDC sponsorship of conferences. If you plan to
hold a conference, you must send a copy of the agenda to CDC's
Procurement and Grants Office.
9. If you plan to use materials using CDC's name, send a copy of
the proposed material to CDC's Procurement and Grants Office for
approval.
Note: Send all reports (except for items 1 and 6) to the Grants
Management Specialist identified in the ``Agency Contacts'' section
of this announcement.
VII. Agency Contacts
For general questions about this announcement, contact: Technical
Information Management Section, CDC Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2700.
For program technical assistance, contact: Victoria Rayle, Project
Officer, Prevention Program Branch, Division of HIV/AIDS Prevention,
Centers for Disease Control and Prevention, 1600 Clifton Road, MS-E58,
Telephone: 404-639-4274, E-mail: vdrl@cdc.gov.
For budget assistance, contact: Jamie Legier, Grants Management
Specialist, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341, Telephone: 770-488-2635, E-mail: bzl3@cdc.gov.
Dated: December 22, 2003.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 03-31972 Filed 12-29-03; 8:45 am]
BILLING CODE 4163-18-P